Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958347 · ClinicalTrials.gov registry record · NA
Omnifit Hydroxylapatite (HA) Hip Outcomes Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT00958347: Clinical Trial NA study, sponsored by Stryker Orthopaedics.
NCT00958347 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 226 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00958347, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The purpose of this study was to obtain up to 25 year post-operative data on the Omnifit Hydroxylapatite (HA) Hip System in support of the hypothesis that it is a satisfactory system for reducing implant loosening, permitting tissue bonding onto the hydroxylapatite surfaces of the implant and providing a safe, efficient, and well-functioning hip in a wide spectrum of clinical circumstances.
Interventions
- DEVICE Omnifit HA Hip Stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 1987-10 |
| Est. Completion | 2011-05 |
| Phase | NA |
Why NCT00958347 stopped before completion
NCT00958347 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Omnifit HA Hip Stem is the first listed.
NCT00958347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00958347 about?
NCT00958347 is a clinical study titled "Omnifit Hydroxylapatite (HA) Hip Outcomes Study". The purpose of this study was to obtain up to 25 year post-operative data on the Omnifit Hydroxylapatite (HA) Hip System in support of the hypothesis that it is a satisfactory system for reducing implant loosening, permitting tissue bonding onto the hydroxylapatite surfaces of the implant and provid...
What is the current status of trial NCT00958347?
This trial is currently terminated. It is a NA study. The enrollment target is 226 participants. The study started on 1987-10. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00958347?
The interventions under investigation include: Omnifit HA Hip Stem (DEVICE).
Who is sponsoring clinical trial NCT00958347?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00958347's enrollment target sits among peer trials
226 471st of 2000 higher than 1,529 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04419272 · 226 participants · Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- NCT05449002 · 226 participants · NA
Digital Single Session Intervention for Youth Mental Health
- NCT05488054 · 226 participants · NA
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
- NCT05924477 · 226 participants · NA
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia